Rothschild & Co Asset Management US’s Merit Medical Systems MMSI Stock Holding History

Rothschild & Co Asset Management US’s Portfolio MMSI Stock Details MMSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$7.87M	Sell	111,451 -11,000	-9%	-$734K	0.12%	129
2022 Q3	$6.92M	Sell	122,451 -15,641	-11%	-$901K	0.12%	142
2022 Q2	$7.49M	Buy	138,092 +18,826	+16%	+$1.15M	0.12%	146
2022 Q1	$7.93M	Sell	119,266 -34,705	-23%	-$2.09M	0.1%	163
2021 Q4	$9.59M	Sell	153,971 -1,801	-1%	-$121K	0.11%	180
2021 Q3	$11.2M	Sell	155,772 -12,187	-7%	-$827K	0.14%	171
2021 Q2	$10.9M	Sell	167,959 -19,089	-10%	-$1.18M	0.13%	178
2021 Q1	$11.2M	Sell	187,048 -84,471	-31%	-$4.84M	0.14%	185
2020 Q4	$15.1M	Sell	271,519 -60,681	-18%	-$3.13M	0.19%	165
2020 Q3	$14.5M	Sell	332,200 -71,413	-18%	-$3.23M	0.26%	159
2020 Q2	$18.4M	Sell	403,613 -110,835	-22%	-$4.47M	0.27%	157
2020 Q1	$16.1M	Sell	514,448 -70,844	-12%	-$2.52M	0.25%	154
2019 Q4	$18.3M	Sell	585,292 -416,973	-42%	-$11.9M	0.19%	200
2019 Q3	$30.5M	Buy	1,002,265 +740,465	+283%	+$30M	0.33%	129
2019 Q2	$15.6M	Sell	261,800 -240,676	-48%	-$13.8M	0.17%	214
2019 Q1	$31.1M	Sell	502,476 -11,685	-2%	-$663K	0.33%	109
2018 Q4	$28.7M	Sell	514,161 -36,669	-7%	-$2.18M	0.35%	103
2018 Q3	$33.8M	Sell	550,830 -12,389	-2%	-$712K	0.35%	107
2018 Q2	$28.8M	Sell	563,219 -77,267	-12%	-$3.83M	0.31%	133
2018 Q1	$29M	Sell	640,486 -14,474	-2%	-$655K	0.32%	131
2017 Q4	$28.3M	Sell	654,960 -56,361	-8%	-$2.36M	0.3%	137
2017 Q3	$30.1M	Sell	711,321 -131,701	-16%	-$5.31M	0.33%	123
2017 Q2	$32.2M	Buy	843,022 +21,768	+3%	+$727K	0.36%	89
2017 Q1	$23.7M	Buy	821,254 +9,170	+1%	+$257K	0.27%	142
2016 Q4	$21.5M	Buy	812,084 +88,208	+12%	+$2.13M	0.27%	146
2016 Q3	$17.6M	Buy	723,876 +707,266	+4,258%	+$16.3M	0.3%	134
2016 Q2	$329K	Buy	+16,610	New	+$319K	0.01%	536

Other funds holding MMSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Rothschild & Co Asset Management US's MMSI Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Merit Medical Systems (MMSI) stake by 9% in Q4 2022, selling an estimated $734K and leaving 111,451 shares worth $7.87M. The position accounts for 0.12% of the portfolio, ranked #129.

Rothschild & Co Asset Management US first reported a position in MMSI in Q2 2016 and has held it in 27 quarters since. The position peaked at $33.8M in Q3 2018. 279 funds tracked by Wall St. Rank hold MMSI as of Q4 2022.

Rothschild & Co Asset Management US held 111,451 shares of Merit Medical Systems worth $7.87M as of Q4 2022.
Rothschild & Co Asset Management US sold 11,000 Merit Medical Systems shares in Q4 2022, an estimated $734K.
Merit Medical Systems made up 0.12% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #129 holding.
Rothschild & Co Asset Management US first reported a position in Merit Medical Systems in Q2 2016 and has held it in 27 quarters since.
Rothschild & Co Asset Management US's Merit Medical Systems position peaked at $33.8M in Q3 2018.
279 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.